Partitioning of HIV-1 Gag and Gag-related proteins to membranes

被引:61
作者
Ehrlich, LS
Fong, S
Scarlata, S
Zybarth, G
Carter, C
机构
[1] SUNY STONY BROOK,DEPT MOLEC GENET & MICROBIOL,STONY BROOK,NY 11794
[2] SUNY STONY BROOK,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794
关键词
D O I
10.1021/bi952337x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of HIV-1 Gag and Gag-related proteins to model membranes was examined using three experimental systems: (i) large unilamellar phospholipid vesicles (LUVs) and recombinant Gag purified from Escherichia coli; (ii) LUVs added to a mammalian cell extract in which Gag proteins were expressed by a coupled transcription/translation system; and (iii) inside-out plasma membrane vesicles purified from human red blood cells (RBC) and recombinant, purified Gag from E. coli. Several novel aspects of HIV-1 Gag membrane interactions were observed: (i) Gag proteins bound with high affinity to both model membranes with a negatively charged surface and to RBC membranes. (ii) Binding of the Gag precursor and mature Gag proteins exhibited different sensitivities to ionic strength indicating that the precursor directed membrane binding through interactions that were qualitatively and quantitatively distinct from those of any of its individual domains. Studies using energy transfer between tryptophan residues in the proteins and anthroyloxy-containing probes inserted In the LUVs indicated that the orientation of the precursor and of the mature proteins on the membrane surface were distinct; (iii) Gag oligomers appear to have facilitated high-affinity binding under high salt conditions, suggesting that protein-protein interactions led to formation of stronger electrostatic or new hydrophobic membrane binding determinants. Since binding studies with model membranes permit quantitative analysis, these experimental approaches may permit identification of interactions that drive Gag assembly on the membrane.
引用
收藏
页码:3933 / 3943
页数:11
相关论文
共 46 条
[31]  
PESSIN JE, 1980, J BIOL CHEM, V255, P9044
[32]   CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PR55(GAG) MEMBRANE ASSOCIATION IN A CELL-FREE SYSTEM - REQUIREMENT FOR A C-TERMINAL DOMAIN [J].
PLATT, EJ ;
HAFFAR, OK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4594-4598
[33]   COMPLETE NUCLEOTIDE-SEQUENCE OF THE AIDS VIRUS, HTLV-III [J].
RATNER, L ;
HASELTINE, W ;
PATARCA, R ;
LIVAK, KJ ;
STARCICH, B ;
JOSEPHS, SF ;
DORAN, ER ;
RAFALSKI, JA ;
WHITEHORN, EA ;
BAUMEISTER, K ;
IVANOFF, L ;
PETTEWAY, SR ;
PEARSON, ML ;
LAUTENBERGER, JA ;
PAPAS, TS ;
GHRAYEB, J ;
CHANG, NT ;
GALLO, RC ;
WONGSTAAL, F .
NATURE, 1985, 313 (6000) :277-284
[34]   PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA-1 BINDS WITH HIGH-AFFINITY TO PHOSPHOLIPID-VESICLES CONTAINING PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE [J].
REBECCHI, M ;
PETERSON, A ;
MCLAUGHLIN, S .
BIOCHEMISTRY, 1992, 31 (51) :12742-12747
[35]   FUNCTIONAL DOMAINS OF HIV-1 GAG-POLYPROTEIN EXPRESSED IN BACULOVIRUS-INFECTED CELLS [J].
ROYER, M ;
CERUTTI, M ;
GAY, B ;
HONG, SS ;
DEVAUCHELLE, G ;
BOULANGER, P .
VIROLOGY, 1991, 184 (01) :417-422
[36]   PRODUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-LIKE PARTICLES FROM CELLS INFECTED WITH RECOMBINANT VACCINIA VIRUSES CARRYING THE GAG GENE OF HIV [J].
SHIODA, T ;
SHIBUTA, H .
VIROLOGY, 1990, 175 (01) :139-148
[37]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PR55GAG AND PR160GAG-POL EXPRESSED FROM A SIMIAN-VIRUS 40 LATE REPLACEMENT VECTOR ARE EFFICIENTLY PROCESSED AND ASSEMBLED INTO VIRUSLIKE PARTICLES [J].
SMITH, AJ ;
CHO, MI ;
HAMMARSKJOLD, ML ;
REKOSH, D .
JOURNAL OF VIROLOGY, 1990, 64 (06) :2743-2750
[38]   IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG PROTEIN DOMAINS ESSENTIAL TO MEMBRANE-BINDING AND PARTICLE ASSEMBLY [J].
SPEARMAN, P ;
WANG, JJ ;
VANDERHEYDEN, N ;
RATNER, L .
JOURNAL OF VIROLOGY, 1994, 68 (05) :3232-3242
[39]   DISPOSITION OF MAJOR PROTEINS IN ISOLATED ERYTHROCYTE MEMBRANE - PROTEOLYTIC DISSECTION [J].
STECK, TL ;
FAIRBANKS, G ;
WALLACH, DFH .
BIOCHEMISTRY, 1971, 10 (13) :2617-+
[40]   MODE OF ACTION OF SDZ NIM-811, A NONIMMUNOSUPPRESSIVE CYCLOSPORINE-A ANALOG WITH ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) - INTERFERENCE WITH EARLY AND LATE EVENTS IN HIV-1 REPLICATION [J].
STEINKASSERER, A ;
HARRISON, R ;
BILLICH, A ;
HAMMERSCHMID, F ;
WERNER, G ;
WOLFF, B ;
PEICHL, P ;
PALFI, G ;
SCHNITZEL, W ;
MLYNAR, E ;
ROSENWIRTH, B .
JOURNAL OF VIROLOGY, 1995, 69 (02) :814-824